Forecast: Import of Blood, Antisera, Vaccines, Toxins and Cultures to India

The import of Blood, Antisera, Vaccines, Toxins, and Cultures to India was recorded at approximately 885 million USD in 2023. The forecast data indicates a gradual increase over the coming years, with an estimated value of 913.87 million USD in 2024 and further projected growth to 1031.2 million USD by 2028. Year-on-year variations display a steady increase, with percentage changes fluctuating around 3% to 3.5% annually. The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately 3.08%.

Future trends to observe include:

• Potential impacts of global and local regulatory changes on import dynamics.
• Technological advancements in healthcare influencing demand for vaccines and cultures.
• India's increasing healthcare expenditure and expansion of immunization programs potentially driving import growth.